January 03, 2025

More Coffee, Better Cognition in AF Study

In a study of patients with AF, >5 daily cups of coffee correlated with cognitive performance akin to being 6.7 years younger, alongside reductions in IL-6 levels, highlighting potential anti-inflammatory benefits.

Conexiant

January 03, 2025

Does CVD Correlate with Advanced Breast Cancer?

Case-control study evaluates the association between cardiovascular disease and breast cancer stage at diagnosis, revealing potential links in specific subtypes.

Conexiant

January 02, 2025

Diet Changes May Cut Cognitive Decline Risk

In older adults at risk for dementia, a 24-week Mediterranean diet intervention led to sustained cognitive benefits and improved diet adherence for up to 12 months.

Conexiant

December 30, 2024

Light Wine Consumption May Cut CVD Risk in Half

"It is critical to note that the study’s findings reinforce the notion that these cardiovascular benefits are limited to moderate wine consumption."

Conexiant

December 27, 2024

More Aerobic Minutes Equals More Weight Loss

At 150 minutes per week, participants averaged a weight loss of 2.79 kg, while at 300 minutes per week, weight loss increased to 4.19 kg.

Conexiant

December 19, 2024

Large Acetaminophen Study Reveals New Risks

In a large cohort study of 180,483 acetaminophen users aged 65 or older, researchers found that use was associated with a 36% increased risk of lower gastrointestinal bleeding.

Conexiant

December 18, 2024

Major Heart Failure Trial Yields Key Data

A recent multicenter trial investigated the impact of potassium nitrate supplementation on exercise capacity and quality of life in patients with heart failure with preserved ejection fraction, revealing interesting insights into blood nitric oxide metabolites.

Conexiant

December 16, 2024

Are Dietary Guidelines Built on Solid Research?

A study evaluating systematic reviews used to develop dietary guidelines for Americans revealed 'critically low' quality and significant methodological weaknesses, raising concerns about reliability and reproducibility.

Conexiant

December 16, 2024

FDA 6-Month Drug Pipeline

A pipeline of novel drugs awaits FDA review through the first half of 2025.

Conexiant